New Indications for Somatostatin Analogs

(MedPage Today) -- FDA okayed pasireotide for acromegaly and lanreotide for gastroenteropancreatic neuroendocrine tumors. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1sG9A7m